Effects of hormone replacement therapy on the phospholipid composition of high density lipoproteins in postmenopausal women

Journal of Obstetrics and Gynaecology

Volumn 21, Issue 1, 2001, Pages 56-61

  Papapanagiotou, A ^a   Koufali, M M ^a   Zachari, A ^a   Charalabidou, C ^a   Kalofoutis, A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN; COLPIORNE; CONJUGATED ESTROGEN; ESTROGEN; FOLLITROPIN; GESTAGEN; HIGH DENSITY LIPOPROTEIN; LUTEINIZING HORMONE; MEDROGESTONE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; SPHINGOMYELIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0035124505     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/01443610020022131     Document Type: Article

References (47)

1. Subpopulation of apolipoprotein A-1 in human high density lipoproteins. Their metabolic properties and response to drug therapy
2. Estrogen replacement therapy and cognitive function in older women
3. Changes in lipoproteins and subfractions following oophorectomy and oestrogen replacement in peri-menopausal women
4. Cardiovascular mortality and noncontraceptive use of estrogen in women results from the Lipid Research Clinic Program Follow-up Study
5. Menopausal estrogen use, high density lipoprotein cholesterol subfractions and liver function
6. Distribution of high density lipoprotein particle with different apolipoprotein composition: Particles with A-I and A-II and particles with A-I but no A-II
7. Altered particle size distribution of apolipoprotein A-I containing lipoproteins in subjects with coronary artery disease
8. A dose-response relationship between se steroid hormone induced changes in hepatic triglyceride lipase and high density lipoprotein cholesterol in postmenopausal women
9. Quantitative lipoprotein electrophoresis: Ihre raitinemässige Anwendung im Vergleich mit anderen Verjahren zur differenzierten Untersuchung des Fettstoffwechsels
10. Hormone replacement therapy with dydrogestorone and 17boestradiol: Effects on serum lipoproteins and glucose tolerance during 24 month follow up
11. Correlation of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities
12. Effects of estrogen on low density lipoprotein metabolism in males: Short term and long term studies during hormonal treatment of prostatic carcinoma
13. The risk of acute myocardial infraction after oestrogen and oestrogen-progestogen replacement
14. The effects of conjugated equine oestrogen with and without a cyclical progestogen on lipoproteins and HDL subfractions in postmenopausal women
15. Molecular physiology of reverse cholesterol transport
16. Plasma lipoprotein abnormalities in heterozygotes for familiar lecithin: Cholesterol acyltransferase deficiency
17. Sex steroids and lipoprotein metabolism
18. Postmenopausal estrogen and progestrogen use and the risk of cardiovascular disease
19. Hormone therapy to prevent disease and prolong life in postmenopausal women
20. Ten years post-menopausal hormone replacement therapy=Meffect on lipoproteins
21. Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in post-menopausal women
22. Canine vascular tissues are targets for androgens, progestrogens and glycocorticoids
23. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
24. Human plasma phospholipid transfer protein causes high density lipoprotein conversion
25. High density lipoprotein and coronary atherosclerosis. A strong inverse relation with the largest particles is combined to normotriglyceridemic patients
26. Menopause and risk of cardiovascular disease. The Framingham Study
27. Benefits and risks of estrogen replacement therapy
28. Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17alpha ethinil estradiol
29. Menopause and risk factors for coronary heart disease
30. Effects of conjugated equine estrogen with and without three different progestones on lipoproteins, high density lipoprotein subtractions and apolipoprotein A-I
31. Estradiol-binding sides in rat aortic smooth muscle-cells in culture
32. Purified (Ca2+Mg2+) ATPase of the erythrocyte membrane. Reconstitution and effect of calmodulin and phospholipids
33. Role of lipoprotein lipase and hepatic andothelial lipase in the metabolism of high density lipoproteins: A novel concept on cholesterol transport in HDL cycle
34. Effects of hormone replacement therapy on serum lipids and phospholipids in postmenopausal women
35. Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: A comparison between progestogens and natural progesterone
36. Hormone replacement therapy, hormone levels and lipoprotein cholesterol concentrations in elderly women
37. Apo A-II/apo A-I molar ratio in the HDL particle influences phospholipid transfer protein-mediated HDL interconversion
38. Metabolism of apolipoproteins A-I, A-II and A-IV
39. + stimulated adenosine triphosphate system of brain microsomes
40. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiological evidence
41. The heart: A target organ for estradiol
42. Plasma cholesteryl ester transfer protein
43. Role of plasma lipoprotein in the pathogenesis of atherosclerosis disease with special reference to sex hormone effects
44. Response of HDL subclasses, Lp (A-I) and Lp (A-I: A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women
45. Determination of high density phospholipids and its possible clinical application in the assessment of cardiovascular disease risk
46. Effects of postmenopausal hormone replacement with oral transdermal estrogen on high density lipoprotein metabolism
47. Effects of postmenopausal estrogen replacement on the concentration and metabolism of plasma lipoproteins